Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $836.15 | 23 | 94.3% |
| Gift | $50.40 | 1 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $208.12 | 3 | $0 (2022) |
| Merck Sharp & Dohme LLC | $188.80 | 7 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $158.08 | 3 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $95.98 | 1 | $0 (2022) |
| Chiesi USA, Inc. | $65.58 | 2 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $54.73 | 2 | $0 (2021) |
| Novo Nordisk Inc | $45.00 | 2 | $0 (2023) |
| PBG PUERTO RICO LLC | $32.15 | 2 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $21.82 | 1 | $0 (2023) |
| AbbVie Inc. | $16.29 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $102.42 | 5 | Novo Nordisk Inc ($45.00) |
| 2022 | $480.66 | 8 | Bayer HealthCare Pharmaceuticals Inc. ($208.12) |
| 2021 | $94.91 | 6 | Biohaven Pharmaceuticals, Inc. ($25.46) |
| 2020 | $108.56 | 4 | CHIESI USA, INC. ($50.40) |
| 2018 | $100.00 | 1 | Merck Sharp & Dohme Corporation ($100.00) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/05/2023 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/25/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 04/18/2023 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $21.82 | General |
| 03/03/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
| 12/07/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $95.25 | General |
| Category: Hematology | ||||||
| 10/25/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/07/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $67.04 | General |
| 09/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $45.83 | General |
| 05/23/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $95.98 | General |
| Category: DIABETES | ||||||
| 05/17/2022 | PBG PUERTO RICO LLC | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/10/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: PRIMARY CARE | ||||||
| 08/24/2021 | Merck Sharp & Dohme Corporation | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/01/2021 | PBG PUERTO RICO LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/28/2021 | Merck Sharp & Dohme Corporation | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/23/2021 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $15.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/17/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2020 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: PRIMARY CARE | ||||||
| 10/09/2020 | CHIESI USA, INC. | CLEVIPREX (Drug) | Gift | Cash or cash equivalent | $50.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/24/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/27/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 38 | 38 | $88,674 | $6,654 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 24 | 24 | $61,030 | $4,464 | 7.3% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 14 | 14 | $27,644 | $2,189 | 7.9% |
About Dr. Jose Baster Rojas, MD
Dr. Jose Baster Rojas, MD is a Internal Medicine healthcare provider based in Tavernier, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2017. The National Provider Identifier (NPI) number assigned to this provider is 1700306164.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Baster Rojas, MD has received a total of $886.55 in payments from pharmaceutical and medical device companies, with $102.42 received in 2023. These payments were reported across 24 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($836.15).
As a Medicare-enrolled provider, Baster Rojas has provided services to 38 Medicare beneficiaries, totaling 38 services with total Medicare billing of $6,654. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties General Practice, Student in an Organized Health Care Education/Training Program
- Location Tavernier, FL
- Active Since 06/26/2017
- Last Updated 08/31/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700306164
Products in Payments
- ZERBAXA (Drug) $164.57
- FARXIGA (Drug) $158.08
- JARDIANCE (Drug) $95.98
- Adempas (Drug) $95.25
- CLEVIPREX (Drug) $65.58
- NURTEC ODT (Drug) $54.73
- Ozempic (Drug) $25.00
- RECARBRIO (Drug) $24.23
- Rybelsus (Drug) $20.00
- VYNDAQEL (Drug) $19.15
- SYNTHROID (Drug) $16.29
- ELIQUIS (Drug) $13.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.